AIM
HUM icon

Acrospire Investment Management’s Humana HUM Stock Holding History

Acrospire Investment Management’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$120K – 666
2017
Q2 		$120K Buy
+500
New +$113K 0.11% 155
2017
Q1 		– Sell
-1,300
Closed -$265K – 2327
2016
Q4 		$265K Buy
1,300
+700
+117% +$134K 0.11% 195
2016
Q3 		$106K Buy
+600
New +$104K 0.07% 509

Other funds holding HUM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Acrospire Investment Management's HUM Position: Q3 2017 in Review

Acrospire Investment Management sold out of Humana (HUM) in Q3 2017, closing a stake of 500 shares — an estimated $120K sold.

Acrospire Investment Management first reported a position in HUM in Q3 2016 and held it in 3 quarters. The position peaked at $265K in Q4 2016. 655 funds tracked by Wall St. Rank hold HUM as of Q3 2017.

  • Acrospire Investment Management reported no remaining Humana position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 500 Humana shares in Q3 2017, an estimated $120K.
  • Acrospire Investment Management first reported a position in Humana in Q3 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Humana position peaked at $265K in Q4 2016.
  • 655 funds tracked by Wall St. Rank held Humana as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.